Stock Events

Stock Events

Actuate Therapeutics (ACTU) Q2 2025 Earnings

15MayConfirmed

Q4 2024

Q1 2025

Q2 2025

-0.55

-0.46

-0.38

-0.29

Details

Expected EPS

-0.3

Actual EPS

-0.32

Surprise EPS

-0.02

Surprise Percent

+6.67%

Description

Actuate Therapeutics (ACTU) has reported earnings of -0.32 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.